Why do not traditional Chinese medicine

resources out great industry

      Although our country industry of Chinese modernization and internationalization level rising, but unreasonable structure leads to industry development in the future is insufficient, management "Kowloon water caused some supporting policies failed to play a role, plus the intellectual property rights protection system caused by lack of many traditional Chinese herbal medicines," the secret recipe loss into "Chinese" rant, "such as domestic seizes the market handicap, traditional Chinese medicine industry bigger and stronger faces" inside and outside the negative situation recounted ".

     Structural contradictions restrict development

     Big resources to make the industry

     The author recently in some Chinese herbal medicine a major investigation understands, at present, our country medicine enterprise widespread enterprise scattered, research problems such as weak and small scale, most businesses not form a complete industry chain and scale economic benefit, with products production enterprise, repeat production, leading companies do serious is not strong, the products do not quite, structure contradiction.

      Tianjin medical doctor TianShiLi group ZhuYongHong, guizhou larks pharmaceutical deputy general manager, "says NiuMin scattered, small, weak" situation caused most of our Chinese medicine enterprises' independent innovation ability is weak, medical science and technology competitiveness level is low. ZhuYongHong say, because of new medicine r&d input more, a long life cycle, risk is big, small and medium-sized pharmaceutical enterprise have no ability to conduct research and development work, some big enterprise and lack of innovation consciousness, costs less, restrict the innovation and development of traditional Chinese medicine industry. NiuMin thinks, at present our country lacks in conformity with market economy technology innovation and resource allocation mechanism to enterprise as the main body of the production, study and research innovation mechanism.

     The author understands from guizhou relevant departments, except independent development and rose to national standards of 154 national medicine preparations outside, successful development of 45 listed Chinese herbal drugs is basically enterprise from outside the introduction of the varieties, display the ability of independent innovation is still relatively weak.

      Chinese medicine academy of sciences in sichuan vice dean ZhaoJunNing said, because of the new drug research initiative and genuine traditional Chinese products related to health, weak ability, quantity less, lack of genuine traditional Chinese drugs long-term, lasting policy guide and special support, directly cause long-term failed to get some Chinese medicine development and utilization of traditional Chinese medicine industry, authentic drugs to lower, the industrial connection between traditional Chinese medicine resources made it into small industries helpless.

     Has the unique climate condition of Chinese herbal medicine in qiandongnan youdao, accounts for about more than 2830 21.9 per cent of national medicinal species. Long-term studies of Chinese medicine LiuShuHua qiandongnan, said the expert medicinal chemical components have pharmacological activities, no pollution, good quality, but research work on most no. Throughout the country are their authentic materials, but most are still not get scientific and reasonable exploitation.

     Our high-quality authentic medicinal materials into agricultural and sideline products, "great potential failed to get released. The author in yunnan wenshan at sanqi (panax notoginseng) industrial Co., LTD interview acknowledge that sanqi (panax notoginseng) raw material in 2001 through Japan JAS (organic product authentication, the authentication) more than 50 tons each year exported to Japan, but the company's chairman, said more than yukon notoginseng raw materials are as organic food exported to Japan, Japanese processed again after the sale.

     Sichuan province YangDianXing TCM administration chief, said we export is a little value of herbs, not only destroy the ecology, big money still let foreigners to earn. Such as Japan this village pharmaceutical enterprise ChuanBeiMu, used in changbai mountain ginseng is the best medicine.

     "Kowloon water to make the resultant force

     According to introducing, BuWeiJu management system in the national development and reform commission, ministry of science and technology, ministry of health and social security department, and the ministry of agriculture, state administration of traditional Chinese medicine and other traditional Chinese medicine industry many departments involves management.

    Such as sichuan province, currently involves the industry of Chinese regulators of 15, among them, the development and reform commission, department of Chinese medicine by the ocog and faith, scientific research and innovation project administration shall be responsible for the department of agriculture, forestry bureau, and administration of traditional Chinese medicine, Chinese, development and reform commission is responsible for planting base construction, regulators responsible for drugs, health products registration, the quality control and production access permission, the health department supervisor drug hang nets public bidding, the food and drug homologous product registration license, business hall is responsible for Chinese traditional medicine, yinpian and medicine etc, the letter committee responsible for export industry development and industry management, pharmaceutical reserve, etc.

     Industry insiders thinks generally, "water management situation, Kowloon, because function block splits policy for balanced difficulty bigger. In addition, policy formulation, implementation main responsibility is not clear, easy cause management overlap and blind spots.

     Department of social development in yunnan province in WangZhaoJie said, the assistant director of yunnan province puts forward to 2003 Chinese development planning, but the next 5 years did not publish relevant measures, its reason, is in government level and traditional Chinese medicine development without a dedicated management and coordination agency.

     Guizhou NiuMin said Braun pharmaceutical deputy general manager, the state industrial policy support traditional Chinese medicine, but due to a lack of political integration, conflicting, capital of implementing policy overall efficiency is not high. The company is on the cultivation of TCM is met on multiple department management problems.

     The author in the survey also learned that the improper management because of system not, ideas, not clear, some traditional Chinese medicine facing extinction or erosion secret. Yunnan institute of traditional Chinese medicine ZhengJin, vice President of the pharmaceutical industry association of guangdong province, ZhangJunXiu and YangDianXing etc expert thinks, according to Chinese standard management blindly with western modern pharmaceutical standards, TCM formula, the result is published many secret recipe was leaked.

     According to guizhou administration of traditional Chinese medicine statistic, in recent years guizhou investigation, collecting, collating traditional seedlings medicine, dong medicine such as Chinese medicine national medicine square nearly 1000, but currently the development and production of only 150. Due to the development of quality problem, encountered some old Chinese medicine pharmaceutical enterprise facing some of the secrete recipe extinction.

    International competition become intensified

    Because there are no standards, the Chinese medicine when access to the international market, which has been questioned repeatedly faced "access" barriers.

    In recent years, domestic and international opinion a repeal of TCM frequently caused controversy, the confusion of understanding, not only international ZhongYaoJie itself, depreciate medicine culture are not very important Chinese medicine basic theory to learn and master. Guiyang ZhangYuSui TCM college first hospital experts think, Chinese traditional medicine research passive imitate western medicine mode, with western medicine theory to fixed TCM theory, some enterprises with plant chemical method that traditional Chinese medicine with western medicine is the modernization of traditional Chinese medicine, chemical statistical indicators to measure Chinese medicine clinical effect is standardized.

    Because there are no standards, international never stop lead in Chinese medicine, lead to the question facing barriers to enter the international market. Traditional Chinese medicine globalization alliance chairman, Yale university professor, said ZhengYongJi mainstream American medicine medicine, are still not accept that Chinese medicine not proven by science, medicine, Chinese traditional medicine to treat vary from person to person without process mechanism unable to explain clearly.

     These questions make Chinese medicine go out ropey, at present our country hasn't really get into an herbal medicine clinical, European and American countries TianShiLi company produces only dropping the compound danshen first case become our country through U.S. food and drug administration (FDA) Ⅱ period, enter the FDA clinical trials Ⅲ stage clinical trials.

     Instead, Japan, South Korea, the U.S. and other countries use our country raw material research and occupy the international market. Currently has more than 160 countries in different degrees in the TCM diagnosis by disease, more than 120 countries 170 companies committed to traditional Chinese medicine research and development. If Japan JiuXinDan, the main production in China, is nightfall pill formula in scientific and technological innovation on the basis of JiuXinDan, at present developed by 200 yuan/bottle (20 grains) high occupation such drugs market. South Korea SK in China developed for treating high blood pressure drug gingko leaf extract, with annual sales reached $13 million.

     YangDianXing said, the international application of traditional Chinese medicine and other plant medicine patent number has risen sharply, in some of the world's pharmaceutical giant to reach out into our country, chemical drug glaxosmithkline, Pfizer, Merck multinational giants such as China has invested heavily in Chinese medicine, "the study in China" accounted for proprietary Chinese medicine market share is getting higher and higher. (li will YeJian)